We are delighted to announce the following companies as finalists in our Genesis BioNewsRound Award 2023. Voting is now open for everyone, please click on the voting button below.

  • Astex Pharmaceuticals/MSD

Astex expands drug discovery collaboration with MSD

  • Etcembly

Etcembly reveals world’s first AI generative bispecific T cell engager with picomolar affinity

  • Maxion Therapeutics

Maxion Therapeutics’ $16 million Series A to drive antibody development for previously untreatable ion channel and GPCR-driven diseases

  • NRG Therapeutics

NRG Therapeutics Awarded Second $500K Grant from The Michael J. Fox Foundation to Further Progress Parkinson’s Programme

  • PrecisionLife/LifeArc

Precision Life and LifeArc announce strategic MND/ALS partnership

  • Quadram Institute/Oxford Nanopore

The World Health Organization supports the use of targeted sequencing to detect drug resistance in tuberculosis

Voting will close at 14.00 (GMT) on 7 December 2023

The winner will be announced during the afternoon of the Genesis conference on 7 December 2023.